Restricted accessResearch articleFirst published online 2024-03
Why Did the Rapid Increase of Reflex Molecular Testing of Indeterminate Fine Needle Aspiration Cytologies in the USA Not Impact Thyroidectomy Rates? What Is the Lesson to Be Learned?
HuangY, ChanS, WrightJ, et al.Does the adoption of molecular testing cause decreased thyroidectomy rates in a national cohort? A quasi-experimental study of high- vs. low-adoption states, 2024; 34(3):388–398.
2.
HaugenBR, AlexanderEK, BibleKC, et al.2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016; 26(1):1–133; doi: 10.1089/thy.2015.0020
3.
BongiovanniM, SpitaleA, FaquinWC, et al.The Bethesda system for reporting thyroid cytopathology: A metaanalysis. Acta Cytol, 2012; 56(4):333–339; doi: 10.1159/000339959
4.
GhaznaviSA, ClaytonH, EszlingerM, et al.Accuracy of thyroid fine-needle aspiration cytology: A cyto-histologic correlation study in an integrated Canadian health care region with centralized pathology service. Acta Cytol, 2022; 66(3):171–178; doi: 10.1159/000521562
5.
StewardsonP, EszlingerM, WuJ, et al.Prospective validation of ThyroSPEC molecular testing of indeterminate thyroid nodule cytology following diagnostic pathway optimization. Thyroid, 2023; 33(12):1423–1433; doi: 10.1089/thy.2023.0255
6.
NishinoM, MateoR, KilimH, et al.Repeat fine needle aspiration cytology refines the selection of thyroid nodules for Afirma gene expression classifier testing. Thyroid, 2021; 31(8):1253–1263; doi: 10.1089/thy.2020.0969
7.
YipL. Thoughtful utilization of molecular testing in refining thyroid nodule risk assessment: Do not throw out the baby. Thyroid, 2020; 30(4):474–475; doi: 10.1089/thy.2020.0148
8.
AliSZ, BalochZW, Cochand-PriolletB, et al.The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid, 2023; 33(9):1039–1044; doi: 10.1089/thy.2023.0141
9.
HuTX, NguyenDT, PatelM, et al.The effect modification of ultrasound risk classification on molecular testing in predicting the risk of malignancy in cytologically indeterminate thyroid nodules. Thyroid, 2022; 32(8):905–916; doi: 10.1089/thy.2021.0659
10.
DuranteC, HegedusL, CzarnieckaA, et al.2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. Eur Thyroid J, 2023; 12(5):e230067; doi: 10.1530/ETJ-23-0067
